These mechanisms mediated by LMP1, and also possibly by LMP2A, likely contribute to NPC metastasis, and it is possible that the targeting of N-cadherin and integrin signaling may have therapeutic potential for the treatment of metastatic NPC. This evidence concerns the gene CDH2 and nasopharyngeal carcinoma.